Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-047208
Filing Date
2025-03-31
Accepted
2025-03-31 07:34:35
Documents
29
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K maze-10k-2024.htm 10-K 3720014
2 EX-3.1 maze-ex3_1.htm EX-3.1 63959
3 EX-3.2 maze-ex3_2.htm EX-3.2 313488
4 EX-10.17 maze-ex10_17.htm EX-10.17 33755
5 EX-19.1 maze-ex19_1.htm EX-19.1 87237
6 EX-21.1 maze-ex21_1.htm EX-21.1 1656
7 EX-23.1 maze-ex23_1.htm EX-23.1 2784
8 EX-31.1 maze-ex31_1.htm EX-31.1 14494
9 EX-32.1 maze-ex32_1.htm EX-32.1 11370
10 EX-97.1 maze-ex97_1.htm EX-97.1 82429
11 GRAPHIC img75798095_0.jpg GRAPHIC 676670
12 GRAPHIC img75798095_1.jpg GRAPHIC 1032209
13 GRAPHIC img75798095_2.jpg GRAPHIC 827613
14 GRAPHIC img75798095_3.jpg GRAPHIC 838445
15 GRAPHIC img75798095_4.jpg GRAPHIC 368741
16 GRAPHIC img75798095_5.jpg GRAPHIC 478571
17 GRAPHIC img75798095_6.jpg GRAPHIC 302252
18 GRAPHIC img75798095_7.jpg GRAPHIC 372585
19 GRAPHIC img75798095_8.jpg GRAPHIC 534452
20 GRAPHIC img75798095_9.jpg GRAPHIC 939033
21 GRAPHIC img75798095_10.jpg GRAPHIC 867085
22 GRAPHIC img75798095_11.jpg GRAPHIC 332977
23 GRAPHIC img75798095_12.jpg GRAPHIC 361146
24 GRAPHIC img75798095_13.jpg GRAPHIC 699108
25 GRAPHIC img75798095_14.jpg GRAPHIC 484356
26 GRAPHIC img75798095_15.jpg GRAPHIC 295278
27 GRAPHIC img75798095_16.jpg GRAPHIC 218007
28 GRAPHIC img75798095_17.jpg GRAPHIC 510200
29 GRAPHIC img75798095_18.jpg GRAPHIC 567285
  Complete submission text file 0000950170-25-047208.txt   18283195
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filer) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-42490 | Film No.: 25788928
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)